Polly Huang McMurrin

Polly Huang McMurrin, PhD, is a highly experienced scientific regulatory writer and consultant with a strong background in biomedical sciences. Currently serving as a Scientific Regulatory Writer at SCxCMC since August 2025, Polly previously worked at Syner-G BioPharma Group, where responsibilities included writing IND amendments for PharmatrophiX to support clinical studies. At Sequoia Biotech Consulting, before its merger with Syner-G, Polly authored key regulatory documents for Hologic to ensure compliance with EU IVDR 2017/746. Prior roles include Product Manager at Embi Tec, where marketing materials were developed for laboratory equipment, and Product Development Manager at Katherine Cosmetics, leading product launch strategies. Polly's academic foundation includes a PhD in Biomedical Sciences from UC San Diego, underscored by extensive research experience in reproductive biology and pain processing mechanisms.